Literature DB >> 4682315

Urate deposition disease. How is it regulated and how can it be modified?

J R Klinenberg, R Bluestone, L Schlosstein, J Waisman, M W Whitehouse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4682315     DOI: 10.7326/0003-4819-78-1-99

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

1.  Association between hypouricaemia and jaundice.

Authors:  L Schlosstein; I Kippen; R Bluestone; M W Whitehouse; J R Klinenberg
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

2.  Uric acid, diuretics and the kidney.

Authors: 
Journal:  West J Med       Date:  1978-11

3.  Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy.

Authors:  J D Conger; S A Falk
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

4.  A micropuncture study of the early phase of acute urate nephropathy.

Authors:  J D Conger; S A Falk; S J Guggenheim; T J Burke
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

5.  Uric acid effects on in vitro models of rheumatoid inflammatory and autoimmune processes.

Authors:  R A Turner; E J Pisko; C A Agudelo; G B Counts; S L Foster; W J Treadway
Journal:  Ann Rheum Dis       Date:  1983-06       Impact factor: 19.103

6.  Serum 17-beta-estradiol and testosterone levels in asymptomatic hyperuricaemic men.

Authors:  R Rosen; Y Tomer; R Carel; A Weinberger
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

7.  Plasma and synovial fluid as solvents for monosodium urate.

Authors:  R W Dorner; T D Weiss; A R Baldassare; T L Moore; J Zuckner
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.